BioGraph 55

San Francisco, CA · Founded 2014 · Privately Held (backing)

Developer of novel B-cell therapies and drugs designed to address significant unmet clinical needs of autoimmunity. BioGraph 55 is based in San Francisco, CA and was founded in 2014. Its last known valuation is $25 million. It has raised $20.1 million.

Last price · $/share

—

Implied valuation

$25.0M

Total raised

$20.1M

Last round

—

How much has BioGraph 55 raised?

$20.1Macross 0 recorded rounds

Free account

More of BioGraph 55 with a free account

·Watch BioGraph 55: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

BioGraph 55 investors

6 investors are on record for BioGraph 55, including University of California, Pfizer Ventures, Red Tree Venture Capital and Panacea Venture.

For fundraisers

Raising for a company like BioGraph 55?

6 investors have backed BioGraph 55.

See all 6 investors →

Frequently asked about BioGraph 55

How much has BioGraph 55 raised?: BioGraph 55 has raised $20.1M in total across 0 recorded funding rounds.